Highlights Hikma Pharmaceuticals PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:15 2024-05-02 am EDT			5-day change	1st Jan Change
1,925 ^GBX	-0.52%		+5.83%	+7.60%

Apr. 26	HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets
Apr. 25	Hikma Pharmaceuticals backs outlook after making strong start to 2024	AN

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	Apr. 26
Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	Apr. 25	CI
Hikma Pharmaceuticals backs outlook after making strong start to 2024	Apr. 25	AN
Hikma Pharmaceuticals Affirms FY24 Guidance	Apr. 25	MT
Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023	Apr. 25	CI
Hikma Pharmaceuticals plc Reiterates Earnings Guidance for the Year 2024	Apr. 25	CI
Final dividend	Mar. 20	FA
FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data	Mar. 11	DJ
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	Mar. 03	MT
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	Mar. 03	CI
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	Feb. 28	MT
Merck's Bridion faces generic threat from drugmaker Hikma	Feb. 26	RE
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	Feb. 22
Hikma boosts dividend after year of "significant progress"	Feb. 22	AN
Drugmaker Hikma expects profit to be slightly lower in 2024	Feb. 22	RE
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	Feb. 22	MT
Earnings Flash (HIK.L) HIKMA PHARMACEUTICALS Posts FY23 EPS $0.85	Feb. 22	MT
Hikma Pharmaceuticals PLC Provides Group Earnings Guidance for the Year 2024	Feb. 22	CI
Hikma Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Stocks to rise as Nvidia drives AI optimism	Feb. 22	AN

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am EDT